A Long-term, Randomized, Double-blind, Multicenter, Parallel-group, Phase III Study Evaluating the Efficacy and Safety of PT027 Compared to PT007 Administered as Needed in Response to Symptoms in Symptomatic Adults and Children 4 Years of Age or Older

Project: Other project

StatusActive
Effective start/end date7/22/197/21/21

Funding

  • Bond Avillion 2 Development LP: $8,076.92